Principal Scientist, Antibody Discovery and Engineering
Moderna
Summary
Moderna is seeking an accomplished and highly motivated Principal Scientist to join the Antibody Discovery team within Therapeutics Research. This Principal Scientist will lead integrated antibody discovery and engineering campaigns across oncology and autoimmune disease programs, spanning concept development through lead identification.
Job description
Here's What You'll Do
- Lead integrated antibody discovery and engineering campaigns from early concept through lead identification, optimization, and nomination.
- Develop discovery strategies that incorporate target and antigen evaluation, immunization design, B cell screening, display-based engineering, sequence analysis, and data-driven lead selection.
- Design, execute, and oversee antibody generation and optimization workflows, including immunizations, B cell discovery, yeast or other display campaigns, affinity maturation, humanization, format conversion, expression, purification, and characterization.
- Engineer and evaluate antibodies across multiple therapeutic formats, including IgG, Fab, scFv, bispecific or multispecific antibodies, T cell engagers, TCR engagers, CAR-T-related formats, and other novel modalities.
- Characterize antibody candidates using biochemical, biophysical, and functional assays to assess binding, affinity, specificity, epitope diversity, developability, potency, and mechanism of action.
- Partner with antigen design, structural biology, computational biology, and project teams to move programs efficiently from scientific concept to actionable lead molecules.
- Analyze complex datasets, identify scientific and technical risks, and develop practical mitigation strategies that guide program decisions.
- Monitor emerging antibody discovery and engineering technologies and translate relevant advances into ideas that strengthen Moderna's therapeutic discovery capabilities.
- Prepare clear technical reports, project plans, and presentations for internal teams, collaborators, governance forums, and leadership.
- Lead cross-functional scientific discussions, manage external partners, and mentor scientists or research associates as appropriate.
Here's What You'll Need (Basic Qualifications)
- PhD in immunology, molecular biology, biochemistry, protein engineering, cancer biology, or a related discipline, with 5+ years of relevant post-PhD industry experience in antibody discovery, antibody engineering, or biologics discovery.
- Demonstrated track record independently leading therapeutic antibody discovery campaigns from concept through lead identification, optimization, or nomination.
- Deep technical expertise in antibody biology, antibody structure and function, discovery platforms, and therapeutic antibody optimization.
- Hands-on experience with immunization-based antibody discovery, including antigen design, immunization strategy, B cell screening, single-cell sorting, B cell culturing, antibody sequence recovery, and NGS-informed repertoire analysis.
- Strong expertise in display technologies for antibody engineering, affinity maturation, specificity optimization, developability improvement, and molecular-format optimization.
- Strong molecular biology and antibody engineering skills, including cloning, library construction, sequence analysis, expression construct design, antibody expression, purification, and analytical characterization.
- Expertise in antibody characterization assays and platforms, including affinity determination, epitope binning, competition assays, specificity profiling, developability assessment, Biacore, Carterra, Octet, ELISA, MSD, multi-parameter flow cytometry, or related technologies.
- Experience developing, executing, and troubleshooting functional cell-based assays relevant to therapeutic antibody discovery.
- Proven ability to design, manage, and critically evaluate outsourced antibody discovery, engineering, and characterization workflows at CROs.
- Strong project leadership skills, including the ability to manage multiple programs, timelines, stakeholders, datasets, and external partnerships simultaneously.
- Excellent analytical, organizational, written, oral, and interpersonal communication skills, with the ability to translate complex scientific issues into clear recommendations.
- Collaborative, proactive, resourceful approach to working in a fast-paced, cross-functional, matrixed research environment.
Here's What You'll Bring to the Table (Preferred Qualifications)
- PhD in relevant discipline and 7+ years of hands on antibody discovery and engineering including prior experience with yeast or mammalian display technologies for antibody discovery and optimization.
- Experience with advanced antibody-based therapeutic formats, such as T cell engagers, TCR engagers, bispecific or multispecific antibodies, ADCs, CAR-T or CAR-NK-related approaches.
- Familiarity with immune-cell biology, primary-cell assays, functional immunology assays, or immune-cell redirecting therapeutic mechanisms.
- Experience applying antibody discovery or engineering approaches across oncology, autoimmune, infectious disease, or other therapeutically relevant areas.
- Familiarity with antibody sequence analysis, bioinformatics, structural modeling, AI/ML-enabled discovery tools, or developability prediction platforms.
- Track record of scientific impact through publications, patents, presentations, therapeutic discovery programs, or implementation of new discovery technologies.
- Experience mentoring junior scientists, leading project teams, or influencing cross-functional scientific strategy.
Requirements
- PhD in immunology, molecular biology, biochemistry, protein engineering, cancer biology, or a related discipline
- 5+ years of relevant post-PhD industry experience in antibody discovery, antibody engineering, or biologics discovery
- Demonstrated track record independently leading therapeutic antibody discovery campaigns from concept through lead identification, optimization, or nomination
- Deep technical expertise in antibody biology, antibody structure and function, discovery platforms, and therapeutic antibody optimization
- Hands-on experience with immunization-based antibody discovery, including antigen design, immunization strategy, B cell screening, single-cell sorting, B cell culturing, antibody sequence recovery, and NGS-informed repertoire analysis
- Strong expertise in display technologies for antibody engineering, affinity maturation, specificity optimization, developability improvement, and molecular-format optimization
- Strong molecular biology and antibody engineering skills, including cloning, library construction, sequence analysis, expression construct design, antibody expression, purification, and analytical characterization
- Expertise in antibody characterization assays and platforms, including affinity determination, epitope binning, competition assays, specificity profiling, developability assessment, Biacore, Carterra, Octet, ELISA, MSD, multi-parameter flow cytometry, or related technologies
- Experience developing, executing, and troubleshooting functional cell-based assays relevant to therapeutic antibody discovery
- Proven ability to design, manage, and critically evaluate outsourced antibody discovery, engineering, and characterization workflows at CROs
- Strong project leadership skills, including the ability to manage multiple programs, timelines, stakeholders, datasets, and external partnerships simultaneously
- Excellent analytical, organizational, written, oral, and interpersonal communication skills
- Collaborative, proactive, resourceful approach to working in a fast-paced, cross-functional, matrixed research environment
Benefits
- Competitive healthcare
- Voluntary benefit programs
- Fitness support
- Mindfulness support
- Mental health support
- Fertility support
- Adoption support
- Surrogacy support
- Generous paid time off
- Volunteer days
- Sabbatical
- Global recharge days
- Year-end shutdown
- Savings and investments
- Location-specific perks
Company overview
Moderna, Inc. is a pioneering American biotechnology and pharmaceutical company headquartered in Cambridge, Massachusetts, that has revolutionized the field of medicine through its groundbreaking messenger RNA (mRNA) technology. Founded in 2010, the company has established itself as a global leader in RNA therapeutics, primarily focusing on mRNA vaccines and treatments. Moderna's innovative platform uses mRNA to provide cellular instructions for producing proteins that trigger immune responses, creating a new category of medicines with significant potential to improve patient outcomes across various therapeutic areas. The company gained worldwide recognition during the COVID-19 pandemic for developing one of the earliest and most effective mRNA vaccines, which demonstrated the transformative potential of its technology platform. Beyond infectious diseases, Moderna is advancing a diverse pipeline of 44 treatment and vaccine candidates across infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune conditions. With approximately 5,800 employees and a strong commitment to scientific innovation, Moderna continues to expand its manufacturing capabilities and research initiatives to deliver the greatest possible impact through mRNA medicines.